ArticleAtherosclerosis2015

Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study.

Yashashwi Pokharel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.